Clinical Trials

Home/Clinical Trials

Researchers turn to creative approaches to battle kidney stones

Can a high-tech water bottle help reduce the recurrence of kidney stones? What about a financial incentive? Those are questions researchers funded by the National Institutes of Health will seek to answer as they begin recruiting participants for a two-year clinical trial at four sites across the country. Scientists will test whether using a smart

September 15th, 2017|Categories: Clinical Trials, Kidney Disease|Tags: |

NIH Funds SLU Research of Possible Treatment for Drug-Resistant TB

Saint Louis University is leading a multi-national clinical trial of what could become a regimen for drug resistant tuberculosis (TB) that does not require injectable medications. The project is funded by a $6.4 million task order from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Daniel

Oral Basal Insulin Shows Promise in Type 2 Diabetes

SAN DIEGO — An oral basal insulin formulation has produced glycemic control equivalent to that of injected insulin glargine in insulin-naïve type 2 diabetes patients. Results from a phase 2a Novo Nordisk–sponsored feasibility study were presented on June 13 here at the American Diabetes Association (ADA) 2017 Scientific Sessions by Leona Plum-Mörschel, PD, chief executive officer

Could a Dog Vaccine Help Save Kids With Brain Cancer?

By: Laura Goldman, Care2.com, April 17, 2017 The statistics are grim: About 60 to 70 percent of children who have glioblastoma, a form of brain cancer, do not survive more than two years. This fast-growing cancer is resistant to traditional treatments like radiation and chemotherapy. For dogs, cancer statistics are also grim. More than 6

Stem cell transplants may induce long-term remission of multiple sclerosis

Wednesday, February 1, 2017 Encouraging results help set stage for larger studies. New clinical trial results provide evidence that high-dose immunosuppressive therapy followed by transplantation of a person's own blood-forming stem cells can induce sustained remission of relapsing-remitting multiple sclerosis (MS), an autoimmune disease in which the immune system attacks the central nervous system. “...these

Stem cell therapy trial at Sanford first of its kind in U.S. for shoulder injuries

FDA-approved study explores utility of fat-derived stem cells SIOUX FALLS, S.D. – The first FDA-approved clinical trial of its kind in the United States using a person’s own fat-derived adult stem cells to treat shoulder injuries is available at Sanford Health. The trial opened in December and explores if adipose stem cells, which are taken